Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Joshua M Eizen

See Remarks at AN2 Therapeutics, Inc. (ANTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $53K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 10SEC ANTXAN2 Therapeutics, Inc. Sell 5,945206,554 held (−3%) $4.17 $25K -18.9%
Jan 7SEC ANTXAN2 Therapeutics, Inc. Sell 17,923159,430 held (−10%) $1.00 $18K +238.0%
Jan 7SEC ANTXAN2 Therapeutics, Inc. Sell 6,931152,499 held (−4%) $1.01 $7K +234.7%
Nov 6SEC ANTXAN2 Therapeutics, Inc. Sell 2,819177,353 held (−2%) $1.14 $3K +196.5%